ProfileGDS5822 / ILMN_1231561
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 50% 28% 3% 21% 23% 36% 0% 27% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 121.950
GSM1276600PDAC Late Ablation Control 216.828
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 16.13
GSM1276603PDAC Late Ablation 212.421
GSM1276604PDAC Late Ablation 313.223
GSM1303940PDAC Late Ablation_anti-CTLA4 117.236
GSM1303941PDAC Late Ablation_anti-CTLA4 20.30
GSM1303942PDAC Late Ablation_anti-CTLA4 313.527